1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1177/1043454206296026" target="_blank" rel="noreferrer">http://doi.org/10.1177/1043454206296026</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Propofol use in pediatric patients with severe cancer pain at the end of life
Publisher
An entity responsible for making the resource available
Journal Of Pediatric Oncology Nursing
Date
A point or period of time associated with an event in the lifecycle of the resource
2007
Subject
The topic of the resource
Child; Humans; Palliative Care; Terminal Care; Pain/drug therapy/etiology; Neoplasms/complications; Propofol/therapeutic use
Creator
An entity primarily responsible for making the resource
Hooke MC; Grund E; Quammen H; Miller B; McCormick P; Bostrom B
Description
An account of the resource
This article describes the use and effectiveness of adjuvant propofol for pain control for pediatric oncology patients at the end of life. All patients experienced severe pain and agitation, not well controlled by continuous infusion opioids and benzodiazepines. Upon starting propofol, most patients had a temporary stabilization in the dose of opioids with subjective improvement in pain control, increased alertness, and improved ability to interact. Propofol infusions were continued until death in most patients. Two patients received propofol infusions at home. Subsequent increases in opioids in 6 patients and propofol in all patients were required for optimal pain control. Adverse effects included agitation in 5 patients and hallucinations in 2, which were controllable with benzodiazepines. One patient developed severe tetany, requiring propofol interruption; propofol was successfully restarted at a lower dose with an adjuvant benzodiazepine. The authors conclude that propofol is a useful and tolerable adjuvant agent for pain management in pediatric oncology patients at the end of life. It is a useful adjuvant if pain is unresponsive to continuous infusion opioids or if rapidly escalating doses of opioids are required.
2007
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1177/1043454206296026" target="_blank" rel="noreferrer">10.1177/1043454206296026</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2007
Backlog
Bostrom B
Child
Grund E
Hooke MC
Humans
Journal Article
Journal Of Pediatric Oncology Nursing
McCormick P
Miller B
Neoplasms/complications
Pain/drug therapy/etiology
Palliative Care
Propofol/therapeutic use
Quammen H
Terminal Care